HANCOCK WHITNEY CORP - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.

Quarter-by-quarter ownership
HANCOCK WHITNEY CORP ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2022$381,000
+44.9%
5,777
+40.6%
0.02%
+77.8%
Q1 2022$263,000
-45.8%
4,110
-9.2%
0.01%
-40.0%
Q4 2021$485,000
-6.6%
4,526
-10.4%
0.02%
-16.7%
Q3 2021$519,000
+16.1%
5,052
-0.5%
0.02%
+28.6%
Q2 2021$447,000
-7.5%
5,078
+2.1%
0.01%
-12.5%
Q1 2021$483,000
-14.8%
4,972
-1.7%
0.02%
-15.8%
Q4 2020$567,0005,0560.02%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 423,012$41,129,0007.43%
Eagle Health Investments LP 133,163$12,947,0005.08%
DAFNA Capital Management LLC 207,911$20,215,0004.80%
Casdin Capital, LLC 1,550,000$150,707,0004.49%
SIB LLC 65,151$6,335,0003.72%
CADIAN CAPITAL MANAGEMENT, LP 913,702$88,839,0003.29%
Integral Health Asset Management, LLC 117,500$11,425,0003.26%
Rock Springs Capital Management LP 746,732$72,605,0001.58%
Avidity Partners Management LP 546,000$53,088,0001.47%
Zebra Capital Management LLC 12,698$1,235,0001.36%
View complete list of BLUEPRINT MEDICINES CORP shareholders